Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.

Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.

Bibliographic Details
Main Author:	PLOS ONE Editors
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0225971

Similar Items

Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
by: Yinjie Gao, et al.
Published: (2016-01-01)

Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Circulating FoxP3+ regulatory T and interleukin17-producing Th17 cells actively influence HBV clearance in de novo Hepatitis B virus infected patients after orthotopic liver transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Intraoperative Cryoprecipitate Transfusion and Its Association with the Incidence of Biliary Complications after Liver Transplantation-A Retrospective Cohort Study.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: De novo Cancers Following Liver Transplantation: A Single Center Experience in China.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Role of Hepatitis C Virus Induced Osteopontin in Epithelial to Mesenchymal Transition, Migration and Invasion of Hepatocytes.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: The Immunoregulation Effect of Alpha 1-Antitrypsin Prolong β-Cell Survival after Transplantation.
by: PLOS ONE Editors
Published: (2018-01-01)

Retraction: The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Genetic Polymorphism of Interferon Regulatory Factor 5 (IRF5) Correlates with Allograft Acute Rejection of Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: New Diagnosis and Therapy Model for Ischemic-Type Biliary Lesions following Liver Transplantation-A Retrospective Cohort Study.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Activation of TGF-β1 Promoter by Hepatitis C Virus-Induced AP-1 and Sp1: Role of TGF-β1 in Hepatic Stellate Cell Activation and Invasion.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression.
by: PLOS ONE Editors
Published: (2019-01-01)

The Impact of Sirolimus on hepatitis C Recurrence after Liver Transplantation
by: Sonal Asthana, et al.
Published: (2011-01-01)

Retraction: Pretransplant Prediction of Posttransplant Survival for Liver Recipients with Benign End-Stage Liver Diseases: A Nonlinear Model.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Interleukin-1β-Induced Autophagy-Related Gene 5 Regulates Proliferation of Embryonic Stem Cell-Derived Odontoblastic Cells.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: An Occult Hepatitis B-Derived Hepatoma Cell Line Carrying Persistent Nuclear Viral DNA and Permissive for Exogenous Hepatitis B Virus Infection.
by: PLOS ONE Editors
Published: (2021-01-01)

The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-03-01)

Retraction: Social success of perfumes.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Inhibition of Spontaneous Recovery of Fear by mGluR5 after Prolonged Extinction Training.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Hepatic Branch Vagus Nerve Plays a Critical Role in the Recovery of Post-Ischemic Glucose Intolerance and Mediates a Neuroprotective Effect by Hypothalamic Orexin-A.
by: PLOS ONE Editors
Published: (2020-01-01)

Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation
by: D Issa, et al.
Published: (2016-01-01)

Retraction: The Different Role of Notch1 and Notch2 in Astrocytic Gliomas.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Perthamide C Inhibits eNOS and iNOS Expression and Has Immunomodulating Activity In Vivo.
by: PLOS ONE Editors
Published: (2019-01-01)

Treatment of recurrent hepatitis C post-liver transplantation
by: Claudio Augusto Marroni
Published: (2010-01-01)

Antiviral therapy for recurrent hepatitis C after liver transplantation and its effect on liver fibrosis
by: ZHOU Shuangnan
Published: (2014-01-01)

Retraction: Hepatitis C Virus Core Protein Down-Regulates p21Waf1/Cip1 and Inhibits Curcumin-Induced Apoptosis through MicroRNA-345 Targeting in Human Hepatoma Cells.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Survival Analysis of Adult Tuberculosis Disease.
by: PLOS ONE Editors
Published: (2018-01-01)

Retraction: SDR9C7 Promotes Lymph Node Metastases in Patients with Esophageal Squamous Cell Carcinoma.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1α.
by: PLOS ONE Editors
Published: (2021-01-01)